Latest news

  • TREATS will begin testing for COVID-19 in Zambia using TB testing facilities

    Friday 28 August

    The TREATS study will soon begin testing for COVID-19 in the Bwacha – Ngungu community of Kabwe in Zambia, using its existing mobile tuberculosis (TB) testing facilities. The 18-month study […]

    Read more
  • Interview Executive Director Mustapha Gidado

    Tuesday 25 August

    He speaks passionate, articulated, and with emphasis on every word. Meet with Dr. Mustapha Gidado and you will get his clear vision on any subject in TB control. The new […]

    Read more
  • Mustapha Gidado new Executive Director of KNCV Tuberculosis Foundation

    Tuesday 25 August

    Dr. Mustapha Gidado takes up the position of Executive Director of KNCV Tuberculosis Foundation. He succeeds Kitty van Weezenbeek, who switched to the World Health Organization (WHO) on 1st May. […]

    Read more
  • KNCV provides hearing aids for Ethiopian TB patients

    Monday 24 August

    It’s been a known fact for years that the treatment for multidrug-resistant tuberculosis, is associated with severe and often permanent hearing loss. This side-effect is caused by second line injectables […]

    Read more
  • The story of Angelito: “99DOTS helped me get cured of TB”

    Friday 14 August

    My name is Angelito* and I am a TB survivor from Mandaluyong City, Philippines. Angelito in his dance costume. “Being an active person I never imagined I would fall ill […]

    Read more
  • Successful KNCV-led TB REACH-projects test Digital Adherence Technologies in the fight against TB

    Friday 14 August

    Since 2018, KNCV has rolled-out several Digital Adherence Technology (DAT) demonstration projects in countries such as the Philippines, Tanzania and Nigeria. These TB REACH projects were funded by the Stop […]

    Read more
  • European approval for new drug against highly resistant TB

    Monday 3 August

    The European Commission has given conditional market authorisation for the three-drug, six-month, all-oral regimen for the treatment of highly resistant tuberculosis (TB). KNCV Tuberculosis Foundation was closely involved in the […]

    Read more
  • Mustapha Gidado new Executive Director of KNCV

    Thursday 30 July

    Dr. Mustapha Gidado is taking office as the new Executive Director of KNCV Tuberculosis Foundation. He succeeds Kitty van Weezenbeek, who transferred to the World Health Organization (WHO) on May […]

    Read more
  • Summary to the KNCV Webinar: Impact of COVID-19: Hear the perspective of TB/MDR-TB patients and front line health care workers

    Wednesday 22 July

    On Thursday 16th of July 2020 KNCV held its next webinar in the KNCV Webinar Series: ‘Contact Investigation for COVID-19: Lessons from TB Control Programs’. During this webinar we heard […]

    Read more
  • KNCV takes over TIME implementation

    Thursday 16 July

    KNCV Tuberculosis Foundation is taking over implementation of the TIME modelling framework from the London School of Hygiene and Tropical Medicine (LSHTM). TIME is a comprehensive and flexible modelling framework […]

    Read more
  • Summary & video of the KNCV Webinar: Contact Investigation for COVID-19: Lessons from TB Control Programs – Part 2

    Monday 13 July

    On 2 July 2020 KNCV held its third webinar in the KNCV Webinar Series: ‘Contact Investigation for COVID-19: Lessons from TB Control Programs – Part 2′. If you missed our […]

    Read more
  • KNCV partners with MSH for Eliminate TB from Ethiopia (ETBE) Project

    Monday 13 July

    The US Agency for International Development (USAID) has granted the Eliminate TB from Ethiopia (ETBE) Project. Management Sciences for Health (MSH) will be in the lead of this five year […]

    Read more